Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First preclinical data supporting AP-23464 as an alternative to Gleevec

July 9, 2003

PI-88 achieves primary efficacy endpoint in multiple myeloma trial

July 9, 2003

Antitumor Cdc25 phosphatase inhibitors designed at Maxia

July 9, 2003

Good tolerability profile reported for IMC-1C11 in patients with metastatic colorectal cancer

July 8, 2003

Phase II trial of GTI-2040 in AML cleared by FDA

July 8, 2003

Roche licenses rights to market Avastin outside the U.S.

July 8, 2003

Erbitux submitted to E.U. and Swiss regulatory authorities

July 8, 2003

New EGFR/HER2 kinase inhibitors under study at Wyeth

July 8, 2003

Approval sought for Plenaxis in Germany

July 7, 2003

Phase I trial initiated for MLN-944

July 7, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...